Hemosphere Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $22M

Hemosphere General Information

Description

Developer of vascular access devices for patients. The company offers hemodialysis reliable outflow vascular access device, an implanted subcutaneous graft with an outflow component that bypasses central venous stenosis that allows for repeated access to the circulation for hemodialysis.

Contact Information

Website
www.hemosphere.com
Formerly Known As
GRAFTcath
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6545 City West Parkway
  • Eden Prairie, MN 55344
  • United States
+1 (952)
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare
Acquirer
Artivion
Vertical(s)
Life Sciences
Corporate Office
  • 6545 City West Parkway
  • Eden Prairie, MN 55344
  • United States
+1 (952)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemosphere Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 16-May-2012 $22M Completed Generating Revenue
6. Later Stage VC 29-Mar-2010 Completed Generating Revenue
5. Later Stage VC (Series D) 10-Mar-2008 Completed Generating Revenue
4. Later Stage VC 12-May-2006 Completed Clinical Trials - General
3. Later Stage VC (Series C) Completed Clinical Trials - General
2. Early Stage VC (Series B) 22-Dec-2003 $5.75M $5.75M Completed Clinical Trials - General
1. Early Stage VC (Series A) Completed Startup
To view Hemosphere’s complete valuation and funding history, request access »

Hemosphere Patents

  • 45

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

Hemosphere Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2013036643-A2 Vascular access system with connector Inactive 06-Sep-2011
WO-2013036643-A3 Vascular access system with connector Inactive 06-Sep-2011
EP-2713949-A1 Implantable and removable customizable body conduit Inactive 01-Jun-2011
EP-2713949-A4 Implantable and removable customizable body conduit Inactive 01-Jun-2011
WO-2012166968-A1 Implantable and removable customizable body conduit Inactive 01-Jun-2011 A61M1/3655
To view Hemosphere’s complete patent history, request access »

Hemosphere Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hemosphere Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Affinity Capital Management Venture Capital Minority
Ascension Ventures Corporate Venture Capital Minority
Cutlass Capital Venture Capital Minority
Emergent Medical Partners Venture Capital Minority
Kaiser Permanente Ventures Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Hemosphere FAQs

  • When was Hemosphere founded?

    Hemosphere was founded in 1998.

  • Where is Hemosphere headquartered?

    Hemosphere is headquartered in Eden Prairie, MN.

  • What is the size of Hemosphere?

    Hemosphere has 8 total employees.

  • What industry is Hemosphere in?

    Hemosphere’s primary industry is Other Devices and Supplies.

  • Is Hemosphere a private or public company?

    Hemosphere is a Private company.

  • What is the current valuation of Hemosphere?

    The current valuation of Hemosphere is .

  • What is Hemosphere’s current revenue?

    The current revenue for Hemosphere is .

  • How much funding has Hemosphere raised over time?

    Hemosphere has raised $26.9M.

  • Who are Hemosphere’s investors?

    Affinity Capital Management, Ascension Ventures, Cutlass Capital, Emergent Medical Partners, and Kaiser Permanente Ventures are 5 of 9 investors who have invested in Hemosphere.

  • When was Hemosphere acquired?

    Hemosphere was acquired on 16-May-2012.

  • Who acquired Hemosphere?

    Hemosphere was acquired by Artivion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process